Specialty reagent provider Maravai LifeSciences has acquired Glen Research Corporation to provide more comprehensive solutions to its customers, says VP.
If reinstated, Donald Trump’s order restricting travel to the US would hurt the cell therapy sector according to the International Society for Cellular Therapy (ISCT).
Under the President’s FY 17 proposed budget request, the FDA would receive $2.743bn in budget authority appropriations – and many are frustrated with the lack of funding.
With the bipartisan 21st Century Cures Act coming up for a vote Friday in the US House, the White House and others are raising a number of concerns over how the bill would be paid for and what it will actually do to speed new cures to market.
The Alliance for a Stronger FDA has expressed disappointment that President Obama’s FY 15 budget request for FDA falls short of what the agency needs to fulfill its responsibilities.
US drug regulators have claimed recent law changes that enhance communication with pharmaceutical manufacturers helped prevent 140 potential drug shortages in 2013.
The Kansas Bioscience Authority has awarded a $400,000 grant to the CRO PRA to create a new program to attract recent college graduates into the clinical research and CRO industries.
Outsourcing-Pharma presents a round-up of the latest appointments in the pharmaceutical outsourcing business, with news from Icon, PPD, Addex, and Cangene.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at PPD, Clinilabs, Clearstone and Clariant.
Wipro Technologies has introduced Rapid Trials to provide clients with a data collection platform that can be deployed quickly and with minimal infrastructure investment.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Ricerca Biosciences, Trialytics, CeeTox and Firecrest Clinical.
The capabilities of the MDS Pharma Services' sites Ricerca is set to acquire "perfectly dovetail" with its existing capacity, according to a company vice president.
